ANTEROGEN CO., LTD.
065660
企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
ANTEROGEN CO., LTD. is a bio venture company that develops and produces therapeutics based on stem cells, which have the ability to differentiate into cells of various tissues, among cell therapies, a type of biopharmaceutical. The company began by establishing a research institute in Boston, United States in 2000, and was the first in South Korea to begin product development research using bone marrow-derived stem cells and adipose-derived stem cells; based on its long experience and accumulated technology, in January 2012 it succeeded in commercializing Cupistem, the world's first adipose-derived stem cell therapy for Crohn's fistula, a rare disease, by obtaining marketing approval.
代表理事
이성구, 김미형(각자대표)
成立日期
2000年3月16日
法人类型
韩国创业板
行业分类
Other specialized wholesale
法人注册号
11011-1909906
营业执照号
108-81-21711
电话号码
02-2104-0391
传真号码
02-2104-0393
公司地址
130 Digital-ro, Geumcheon-gu, Seoul
产品与服务
评论